“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy Analysis of 6-Substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester Derivatives”. International Journal of Pharmaceutical Sciences and Drug Research 16, no. 3 (May 30, 2024): 378–386. Accessed October 15, 2025. https://ijpsdronline.com/index.php/journal/article/view/9307.